GLI1 facilitates the migration and invasion of pancreatic cancer cells through MUC5AC-mediated attenuation of E-cadherin

Oncogene

Volumn 30, Issue 6, 2011, Pages 714-723

  Inaguma, S ^a   Kasai, K ^a   Ikeda, H ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

catenin; E cadherin; GLI1; invasion; MUC5AC; pancreatic cancer

Indexed keywords

BETA CATENIN; DOXYCYCLINE; MUCIN 2; MUCIN 5AC; MUCIN 5B; MUCIN 6; TRANSCRIPTION FACTOR GLI1; TRANSCRIPTION FACTOR GLI2; UVOMORULIN;

ARTICLE; CANCER CELL; CANCER INVASION; CELL ADHESION; CELL CULTURE; CELL JUNCTION; CELL MIGRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PANCREAS CANCER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; TRANSCRIPTION REGULATION; UPREGULATION;

CADHERINS; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; CELL MOVEMENT; HUMANS; MUCIN 5AC; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

ERINACEIDAE;

EID: 79951512092     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.459     Document Type: Article

References (35)

1. Agren M, Kogerman P, Kleman MI, Wessling M, Toftgard R. (2004). Expression of the PTCH1 tumor suppressor gene is regulated by alternative promoters and a single functional Gli-binding site. Gene 330: 101-114. (Pubitemid 38490423)
2. Aishima S, Kuroda Y, Nishihara Y, Taguchi K, Taketomi A, Maehara Y et al. (2006). Gastric mucin phenotype defines tumour progression and prognosis of intrahepatic cholangiocarcinoma: gastric foveolar type is associated with aggressive tumour behaviour. Histopathology 49: 35-44. (Pubitemid 43972918)
3. Al-Aynati MM, Radulovich N, Riddell RH, Tsao MS. (2004). Epithelial-cadherin and beta-catenin expression changes in pancreatic intraepithelial neoplasia. Clin Cancer Res 10: 1235-1240. (Pubitemid 38365212)
4. Bafna S, Kaur S, Batra SK. (2010). Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells. Oncogene 29: 2893-2904.
5. Berman DM, Karhadkar SS, Maitra A, Montes De Oca R, Gerstenblith MR, Briggs K et al. (2003). Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 425: 846-851. (Pubitemid 37351469)
6. Boonla C, Wongkham S, Sheehan JK, Wongkham C, Bhudhisawasdi V, Tepsiri N et al. (2003). Prognostic value of serum MUC5AC mucin in patients with cholangiocarcinoma. Cancer 98: 1438-1443. (Pubitemid 37151499)
7. Briggs CD, Neal CP, Mann CD, Steward WP, Manson MM, Berry DP. (2009). Prognostic molecular markers in cholangiocarcinoma: a systematic review. Eur J Cancer 45: 33-47.
8. Eichberger T, Sander V, Schnidar H, Regl G, Kasper M, Schmid C et al. (2006). Overlapping and distinct transcriptional regulator properties of the GLI1 and GLI2 oncogenes. Genomics 87: 616-632.
9. Gkretsi V, Zhang Y, Tu Y, Chen K, Stolz DB, Yang Y et al. (2005). Physical and functional association of migfilin with cell-cell adhesions. J Cell Sci 118: 697-710. (Pubitemid 40372579)
10. Hollingsworth MA, Swanson BJ. (2004). Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer 4: 45-60. (Pubitemid 38082153)
11. Jepson S, Komatsu M, Haq B, Arango ME, Huang D, Carraway CA et al. (2002). Muc4/sialomucin complex, the intramembrane ErbB2 ligand, induces specific phosphorylation of ErbB2 and enhances expression of p27(kip), but does not activate mitogen-activated kinase or protein kinaseB/Akt pathways. Oncogene 21: 7524-7532. (Pubitemid 35305580)
12. Kasai K, Takahashi M, Osumi N, Sinnarajah S, Takeo T, Ikeda H et al. (2004). The G12 family of heterotrimeric G proteins and Rho GTPase mediate Sonic hedgehog signalling. Genes Cells 9: 49-58. (Pubitemid 38180881)
13. Kasai K, Inaguma S, Yoneyama A, Yoshikawa K, Ikeda H. (2008). SCL/TAL1 interrupting locus derepresses GLI1 from the negative control of suppressor-of-fused in pancreatic cancer cell. Cancer Res 68: 7723-7729.
14. Kasper M, Schnidar H, Neill GW, Hanneder M, Klingler S, Blaas L et al. (2006). Selective modulation of Hedgehog/GLI target gene expression by epidermal growth factor signaling in human keratinocytes. Mol Cell Biol 26: 6283-6298. (Pubitemid 44204544)
15. Lee HS, Lee HK, Kim HS, Yang HK, Kim YI, Kim WH. (2001). MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators. Cancer 92: 1427-1434. (Pubitemid 32947826)
16. 0-flanking region of the human MUC5AC mucin gene and transcriptional up-regulation by bacterial exoproducts. J Biol Chem 273: 6812-6820. (Pubitemid 28160344)
17. Nolan-Stevaux O, Lau J, Truitt ML, Chu GC, Hebrok M, Fernandez-Zapico ME et al. (2009). GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation. Genes Dev 23: 24-36.
18. Park ET, Gum JR, Kakar S, Kwon SW, Deng G, Kim YS. (2008). Aberrant expression of SOX2 upregulates MUC5AC gastric foveolar mucin in mucinous cancers of the colorectum and related lesions. Int J Cancer 122: 1253-1260. (Pubitemid 351287224)
19. Pasca di Magliano M, Sekine S, Ermilov A, Ferris J, Dlugosz AA, Hebrok M. (2006). Hedgehog/Ras interactions regulate early stages of pancreatic cancer. Genes Dev 20: 3161-3173. (Pubitemid 44790630)
20. Prasad NB, Biankin AV, Fukushima N, Maitra A, Dhara S, Elkahloun AG et al. (2005). Gene expression profiles in pancreatic intraepithelial neoplasia reflect the effects of Hedgehog signaling on pancreatic ductal epithelial cells. Cancer Res 65: 1619-1626. (Pubitemid 40478583)
21. Sanada Y, Yoshida K, Ohara M, Oeda M, Konishi K, Tsutani Y. (2006). Histopathologic evaluation of stepwise progression of pancreatic carcinoma with immunohistochemical analysis of gastric epithelial transcription factor SOX2: comparison of expression patterns between invasive components and cancerous or non-neoplastic intraductal components. Pancreas 32: 164-170.
22. Schroeder JA, Thompson MC, Gardner MM, Gendler SJ. (2001). Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland. J Biol Chem 276: 13057-13064.
23. Senapati S, Sharma P, Bafna S, Roy HK, Batra SK. (2008). The MUC gene family: their role in the diagnosis and prognosis of gastric cancer. Histol Histopathol 23: 1541-1552.
24. Shimokawa T, Furukawa Y, Sakai M, Li M, Miwa N, Lin YM et al. (2003). Involvement of the FGF18 gene in colorectal carcinogenesis, as a novel downstream target of the beta-catenin/T-cell factor complex. Cancer Res 63: 6116-6120. (Pubitemid 37255147)
25. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R et al. (1999). The cyclin D1 gene is a target of the beta-catenin/ LEF-1 pathway. Proc Natl Acad Sci USA 96: 5522-5527. (Pubitemid 29234650)
26. Singh AP, Senapati S, Ponnusamy MP, Jain M, Lele SM, Davis JS et al. (2008). Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer. Lancet Oncol 9: 1076-1085.
27. Takikita M, Altekruse S, Lynch CF, Goodman MT, Hernandez BY, Green M et al. (2009). Associations between selected biomarkers and prognosis in a population-based pancreatic cancer tissue microarray. Cancer Res 69: 2950-2955.
28. Thayer SP, di Magliano MP, Heiser PW, Nielsen CM, Roberts DJ, Lauwers GY et al. (2003). Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425: 851-856. (Pubitemid 37355945)
29. Truant S, Bruyneel E, Gouyer V, De Wever O, Pruvot FR, Mareel M et al. (2003). Requirement of both mucins and proteoglycans in cell-cell dissociation and invasiveness of colon carcinoma HT-29 cells. Int J Cancer 104: 683-694. (Pubitemid 36418504)
30. Vincent A, Perrais M, Desseyn JL, Aubert JP, Pigny P, Van Seuningen I. (2007). Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells. Oncogene 26: 6566-6576. (Pubitemid 47530602)
31. Wen Y, Caffrey TC, Wheelock MJ, Johnson KR, Hollingsworth MA. (2003). Nuclear association of the cytoplasmic tail of MUC1 and beta-catenin. J Biol Chem 278: 38029-38039. (Pubitemid 37175334)
32. Yauch RL, Gould SE, Scales SJ, Tang T, Tian H, Ahn CP et al. (2008). A paracrine requirement for hedgehog signalling in cancer. Nature 455: 406-410.
33. Yoon JW, Kita Y, Frank DJ, Majewski RR, Konicek BA, Nobrega MA et al. (2002). Gene expression profiling leads to identification of GLI1-binding elements in target genes and a role for multiple downstream pathways in GLI1-induced cell transformation. J Biol Chem 277: 5548-5555. (Pubitemid 34968606)
34. Yu CJ, Yang PC, Shun CT, Lee YC, Kuo SH, Luh KT. (1996). Overexpression of MUC5 genes is associated with early postoperative metastasis in non-small-cell lung cancer. Int J Cancer 69: 457-465.
35. Yu CJ, Shih JY, Lee YC, Shun CT, Yuan A, Yang PC. (2005). Sialyl Lewis antigens: association with MUC5AC protein and correlation with post-operative recurrence of non-small cell lung cancer. Lung Cancer 47: 59-67. (Pubitemid 39643242)